Efficacy of trifluridine and tipiracil (TAS-102) versus placebo, with supportive care, in a randomized, controlled trial of patients with metastatic colorectal cancer from Spain: results of a subgroup analysis of the phase 3 RECOURSE trial

  1. Longo-Muñoz, F.
  2. Argiles, G.
  3. Tabernero, J.
  4. Cervantes, A.
  5. Gravalos, C.
  6. Pericay, C.
  7. Gil-Calle, S.
  8. Mizuguchi, H.
  9. Carrato-Mena, A.
  10. Limón, M.L.
  11. Garcia-Carbonero, R.
Aldizkaria:
Clinical and Translational Oncology

ISSN: 1699-3055,  1699-048X

Argitalpen urtea: 2017

Alea: 19

Zenbakia: 2

Orrialdeak: 227-235

Mota: Artikulua

DOI: 10.1007/S12094-016-1528-7 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus